Anticonvulsive effects of intracerebroventricular administration of rutin in rats

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 4, 2008, Pages 989-993

  Nassiri Asl, Marjan ^a   Shariati Rad, Schwann ^b   Zamansoltani, Farzaneh ^a  

^a Qazvin University   (Iran)

^b QAZVIN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anticonvulsant; Benzodiazepine; Flavonoids; GABAA receptor; Rutin

Indexed keywords

DIAZEPAM; FLUMAZENIL; PENTETRAZOLE; RUTOSIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLONIC SEIZURE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG STRUCTURE; MALE; NONHUMAN; RAT; TONIC CLONIC SEIZURE;

ANIMALS; ANTICONVULSANTS; BRAIN; CONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY, TONIC-CLONIC; FLUMAZENIL; GABA ANTAGONISTS; GABA MODULATORS; GAMMA-AMINOBUTYRIC ACID; INJECTIONS, INTRAVENTRICULAR; MALE; PENTYLENETETRAZOLE; RATS; RATS, WISTAR; RUTIN; SEIZURES;

EID: 42949110632     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2008.01.011     Document Type: Article

References (42)

1. De Celle T., Heeringa P., Strzelecka A.E., Bast A., Smits J.F., and Janssen B.J. Sustained protective effects of 7-monohydroxyethylrutoside in an in vivo model of cardiac ischemia-reperfusion. Eur J Pharmacol 494 (2004) 205-212
2. Fernandez S.P., Wasowski C., Loscalzo L.M., Granger R.E., Johnston G.A., Paladini A.C., et al. Central nervous system depressant action of flavonoid glycosides. Eur J Pharmacol 539 (2006) 168-176
3. File S.E., and Pellow S. Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788. Psychopharmacology 88 (1989) 1-11
4. Gupta R., Singh M., and Sharma A. Neuroprotective effect of antioxidants on ischaemia and reperfusion-induced cerebral injury. Pharmacol Res 48 (2003) 209-215
5. Hansen S.L., Sperling B.B., and Sanchez C. Anticonvulsant and antiepileptogenic effects of GABAA receptor ligands in pentylenetetrazole-kindled mice. Prog Neuro-Psychopharmacol Biol Psychiatry 28 (2004) 105-113
6. Hosseinzadeh H., Asl M.N., Parvardeh S., and Tagi Mansouri S.M. The effects of carbenoxolone on spatial learning in the Morris water maze task in rats. Med Sci Monit 11 (2005) BR88-BR94
7. Hosseinzadeh H., Parvardeh S., Nassiri Asl M., and Mansouri M.T. Intracerebroventricular administration of thymoquinone, the major constituent of Nigella sativa seeds, suppresses epileptic seizures in rats. Med Sci Monit 11 (2005) BR106-BR110
8. Hosseinzadeh H., and Sadeghnia H.R. Protective effect of safranal on pentylenetetrazol-induced seizures in the rat: involvement of GABAergic and opioids systems. Phytomedicine 14 (2007) 256-262
9. 4-induced hepatotoxicity in rodents. Fitoterapia 73 (2002) 557-563
10. Kahnberg P., Lager E., Rosenberg C., Schougaard J., Camet L., Sterner O., et al. Refinement and evaluation of a pharmacophore model for flavone derivatives binding to the benzodiazepine site of the GABA (A) receptor. J Med Chem 45 (2002) 4188-4120
11. Katsube T., Imawaka N., Kawano Y., Yamazaki Y., Shiwaku K., and Yamane Y. Antioxidant flavonol glycosides in mulberry (Morus alba L.) leaves isolated based on LDL antioxidant activity. Food Chem 97 (2006) 25-31
12. Koehn F.E., and Carter G.T. The evolving role of natural products in drug discovery. Nat Rev Drug Discov 4 (2005) 206-220
13. Kuntic V., Pejic N., Ivkovic B., Vujic Z., Ilic K., Micic S., et al. Isocratic RP-HPLC method for rutin determination in solid oral dosage forms. J Pharm Biomed Anal 43 (2007) 718-721
14. La Casa C., Villegas I., Alarcon de la Lastra C., Motilva V., and Martin Calero M.J. Evidence for protective and antioxidant properties of rutin, a natural flavone, against ethanol induced gastric lesions. J Ethnopharmacol 71 (2000) 45-53
15. Lebeau J., Neviere R., and Cotelle N. Beneficial effects of different flavonoids on functional recovery after ischemia and reperfusion in isolated rat heart. Bioorg Med Chem Lett 11 (2001) 23-27
16. Loscher W., Honack D., Fassbender C.P., and Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models. Epilepsy Res 8 (1991) 171-189
17. Marder M., and Paladini A.C. GABAA-receptor ligands of flavonoid structure. Curr Top Med Chem 2 (2002) 853-867
18. Marder M., Viola H., Wasowski C., Fernandez S., Medina J.H., and Paladini A.C. 6-Methylapigenin and hesperidin: new valeriana flavonoids with activity on the CNS. Pharmacol Biochem Behav 75 (2003) 537-545
19. Medina J.H., Paladini A.C., Wolfman C., Levi de Stein M., Calvo D., Diaz L.E., et al. Chrysin (5-7-di-OH-flavone), a naturally-occurring ligand for benzodiazepine receptors with anticonvulsant properties. Biochem Pharmacol 40 (1990) 2227-2231
20. Medina J.H., Viola H., Wolfman C., Marder M., Wasowski C., Calvo D., et al. Overview. flavonoids: a new family of benzodiazepine receptor ligands. Neurochem Res 22 (1997) 419-425
21. Mellou F., Loutrari H., Stamatis H., Roussos C., and Kolisis F.N. Enzymatic esterification of flavonoids with unsaturated fatty acids: effect of the novel esters on vascular endothelial growth factor release from K562 cells. Process Biochem 41 (2006) 2029-2034
22. Nassiri-Asl M., Shariati-Rad S., and Zamansoltani F. Anticonvulsant effects of aerial parts of Passiflora incarnata extract in mice: involvement of benzodiazepine and opioid receptors. BMC Complement Altern Med 7 (2007) 26
23. Newman D.J., and Cragg G.M. Natural products as sources of new drugs over the last 25 years. J Nat Prod 70 (2007) 461-477
24. Neumayer C., Fugl A., Nanobashvili J., Blumer R., Punz A., Gruber H., et al. Combined enzymatic and antioxidative treatment reduces ischemia-reperfusion injury in rabbit skeletal muscle. J Surg Res 133 (2006) 150-158
25. Nsour W.M., Lau C.B.S., and Wong I.C.K. Review on phytotherapy in epilepsy. Seizure 9 (2000) 96-107
26. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1998), Academic Press, Inc., New York
27. Paladini A.C., Marder M., Viola H., Wolfman C., Wasowski C., and Medina J.H. Flavonoids and the central nervous system: from forgotten factors to potent anxiolytic compounds. J Pharm Pharmacol 51 (1999) 519-526
28. Poole K., Moran N., Bell G., Solomon J., Kendall S., McCarthy M., et al. Patients' perspectives on services for epilepsy: a survey of patient satisfaction, preferences and information provision in 2394 people with epilepsy. Seizure 9 (2000) 551-558
29. Raza M., Shaheen F., Choudhary M.I., Rahman A.U., Sombati S., Suria A., et al. Anticonvulsant effect of FS-1 subfraction isolated from roots of Delphinim denudatum on hippocampal pyramidal neurons. Phytotherapy Res 17 (2003) 38-43
30. Ropper A.H., and Brown R.H. Epilepsy and other seizures disorder. In: Ropper, A.H., Brown, and R.H. (Eds). Adams and Victor's principles of neurology (2005), McGraw-Hill, New York 271-297
31. Sander J.W. The epidemiology of epilepsy revisited. Curr Opin Neurol 16 (2003) 165-170
32. Schwedhelm E., Maas R., Troost R., and Boger R.H. Clinical pharmacokinetics of antioxidants and their impact on systemic oxidative stress. Clin Pharmacokinet 42 (2003) 437-459
33. Sejima H., Ito M., Kishi K., Tsuda H., and Shiraishi H. Regional excitatory and inhibitory amino acid concentration in pentylenetetrazole kindling and kindled rat brain. Brain Dev 19 (1997) 171-175
34. Sheu J.R., Hsiao G., Chou P.H., Shen M.Y., and Chou D.S. Mechanisms involved in the antiplatelet activity of rutin, a glycoside of the flavonol quercetin, in human platelets. J Agric Food Chem 52 (2004) 4414-4418
35. Sucher N.J. Insights from molecular investigations of traditional Chinese herbal stroke medicines: implications for neuroprotective epilepsy therapy. Epilepsy Behav 8 (2006) 350-362
36. Tao Y.H., Jiang D.Y., Xu H.B., and Yang X.L. Inhibitory effect of Erigeron breviscapus extract and its flavonoid components on GABA shunt enzymes. Phytomedicine 15 (2008) 92-97
37. Trumbeckaite S., Bernatoniene J., Majiene D., Jakstas V., Savickas A., and Toleikis A. The effect of flavonoids on rat heart mitochondrial function. Biomed Pharmacother 60 (2006) 245-248
38. Tsang S.Y., and Xue H. Development of effective therapeutics targeting the GABAA receptor: naturally occurring alternatives. Curr Pharm Des 10 (2004) 1035-1044
39. Viola H., Wolfman C., Marder M., Goutman J.D., Bianchin M., Wasowski C., et al. 6-Chloro-3′nitroflavone is a potent ligand for the benzodiazepine binding site of the GABAA receptor devoid of intrinsic activity. Pharmacol Biochem Behav 65 (2000) 313-320
40. Wang F., Shing M., Huen Y., Tsang S.Y., and Xue H. Neuroactive flavonoids interacting with GABAA receptor complex. Curr Drug Targets CNS Neurol Disord 4 (2005) 575-585
41. Wasowski C., Marder M., Viola H., Medina J.H., and Paladini A.C. Isolation and identification of 6-methylapigenin, a competitive ligand for the brain GABAA receptors, from Valeriana wallichii D.C. Planta Med 68 (2002) 934-936
42. Zanoli P., Avallone R., and Baraldi M. Behavioral characterisation of the flavonoids apigenin and chrysin. Fitoterapia 71 (2000) 117-123